The section is under construction. You can read general information about the company. Thank you for understanding.

About the company

Medico-biological scientific-production complex Cytomed (MBNPK Cytomed)

MBNPK Cytomed is an innovative scientific-production pharmaceutical company. The company was established in 1989 to develop and carry out clinical practice implementation of original medications based on research concerning how peptides influence the human body. Peptides are specific biologically active substances extracted from various animal organs and tissues (brain, thymus and pineal glands, spleen, gastrointestinal tract, etc.).

As experiments — launched as far as in 1970s by S. M. Kirov Military Medical Academy scientists — show, administering peptides to the body facilitates restoration of specific organ and tissue functions, suppressed due to pathological processes or aging. In other words, peptides — sometimes referred to as “cytomedines” — are biological correctors of bodily functions, that can be used to prevent various diseases and pathological conditions. Specialists of MBNPK Cytomed have continued to carry out studies initiated by Russian military medics. They have introduced unique peptide-based medications to the clinical practice and developed an associated industrial production technology including synthesis of required molecules.

For more than 25 years, MBPK Cytomed peptide-based drugs have been used in the following medical fields:

  • immunomodulatory agents;
  • anti-inflammatory drugs;
  • indirect action drugs able to inhibit bacterial and viral infections.

Presently, the company offers a range of about 10 patented innovative medical products, designed for prophylaxis and treatment of influenza, acute respiratory diseases and inflammatory processes, immunomodulation therapy, reproductive health restoration, etc.
MBPNK Cytomed works in accordance with international GMP (Good Manufacturing Practice) standards, operates its own scientific laboratory complex, has production facilities in Finland (CYTOMED OY) and Saint-Petersburg, while building a new plant in the Novoorlovskaya special economic zone.».

All the MBPNK Cytomed pharmaceuticals are innovative original Russian medications designed to provide effective aid to people while improving their quality of life.